Neck Carcinoma — Trials

Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,419 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 464
Recruiting: 240
Ph III recruiting: 63
Growth YoY: +3.1%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 31.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (128)

clinicaltrialsPublishedShowing 51–100 of 313 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06947668	Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel(DoIT_Neck)	recruiting	—	250	University of Erlangen-Nürnberg Medical SchoolOTHER	1	Jul 31, 2026	clinicaltrials
NCT07172256	CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs	recruiting	Phase 2	30	Yale UniversityOTHER	1	Jul 30, 2026